Viewing Study NCT07266805

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:30 AM
Ignite Modification Date: 2026-05-26 @ 6:53 PM
Study NCT ID: NCT07266805
Status: RECRUITING
Last Update Posted: 2025-12-05
First Post: 2025-10-20
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant IR Capsule for On-Demand Treatment of Angioedema Attacks in Adults With Acquired Angioedema Due to C1 Inhibitor Deficiency
Sponsor: Pharvaris Netherlands B.V.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Acquired Angioedema-C1-INH View
None AAE-C1-INH View
None Oral Treatment View
None deucrictibant View
None Prophylaxis View
None On-demand View
None C1-Inhibitor Deficiency View
None PHA121 View
None Pharvaris View
None Bradykinin B2 Receptor Antagonists View
None Angioedema View
None Acquired View
None Acquired angioedema View